
<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>volume-11-issue-1-march-2025 &#8211; JCE &#8211; Journal of Cardiovascular Emergencies</title>
	<atom:link href="https://www.jce.ro/issue/volume-11-issue-1-march-2025/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.jce.ro</link>
	<description>Cardiology,  Emergency Medicine and Intensive-Care Medicine, Radiology</description>
	<lastBuildDate>Sat, 15 Mar 2025 08:26:52 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title>The Evolution of Computer-assisted Detection of Pulmonary Embolism from Volume to Voxel</title>
		<link>https://www.jce.ro/article/the-evolution-of-computer-assisted-detection-of-pulmonary-embolism-from-volume-to-voxel/</link>
		
		<dc:creator><![CDATA[Florin Condrea, Saikiran Rapaka, Lucian Itu, Marius Leordeanua]]></dc:creator>
		<pubDate>Sat, 15 Mar 2025 08:26:52 +0000</pubDate>
				<guid isPermaLink="false">https://www.jce.ro/?post_type=article&#038;p=2646</guid>

					<description><![CDATA[ABSTRACT Pulmonary embolism (PE) remains a significant cause of cardiovascular mortality, with <a class="more-link" href="https://www.jce.ro/article/the-evolution-of-computer-assisted-detection-of-pulmonary-embolism-from-volume-to-voxel/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><strong>ABSTRACT</strong></p>
<p>Pulmonary embolism (PE) remains a significant cause of cardiovascular mortality, with un- treated cases showing mortality rates of up to 30%. The evolution of computer-assisted detec- tion (CAD) for PE has transformed dramatically over the past decades, progressing from simple pattern recognition to sophisticated deep learning approaches. Early CAD systems demonstrat- ed modest performance, with sensitivity around 75% at 2–4 false positives per scan, whereas modern deep learning architectures achieve sensitivities of up to 92.9% at 0.15 false positives per scan. Significantly, the technological progression has evolved from basic patient-level clas- sification to sophisticated voxel-level analysis. This review provides a comprehensive overview of the evolution of PE CAD systems, their clinical value, and future directions.</p>
</div>
</div>
</div>
</div>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>The Role of Serum Biomarkers in the Prediction of Immediate Postoperative Complications after Carotid Endarterectomy</title>
		<link>https://www.jce.ro/article/the-role-of-serum-biomarkers-in-the-prediction-of-immediate-postoperative-complications-after-carotid-endarterectomy/</link>
		
		<dc:creator><![CDATA[Ioan Alexandru Balmos, Adina Hutanu, Emőke Horváth, Paul-Adrian Calburean, Gyopár Beáta Molnár, Adrian Vasile Muresan]]></dc:creator>
		<pubDate>Tue, 11 Mar 2025 08:21:01 +0000</pubDate>
				<guid isPermaLink="false">https://www.jce.ro/?post_type=article&#038;p=2643</guid>

					<description><![CDATA[ABSTRACT Background: Severe carotid stenosis is a significant cause of stroke and <a class="more-link" href="https://www.jce.ro/article/the-role-of-serum-biomarkers-in-the-prediction-of-immediate-postoperative-complications-after-carotid-endarterectomy/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<div class="page" title="Page 30">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><strong>ABSTRACT</strong></p>
<p><strong>Background:</strong> Severe carotid stenosis is a significant cause of stroke and transient ischemic attack. The most common surgical treatment of this pathology aimed at reducing neurologi- cal complications is carotid endarterectomy (CEA), a procedure associated with a low rate of postoperative complications and improved quality of life. The aim of this study was to identify serum biomarkers that can predict immediate postoperative complications following CEA. <strong>Methods:</strong> This prospective study was conducted over 1 year at the Department of Vascular Surgery of the County Emergency Clinical Hospital of Târgu Mureș, Romania. A total of 46 patients with severe carotid stenosis who underwent CEA were included in the study. Blood samples were collected before surgery to determine the levels of serum biomarkers, and the patients were monitored postoperatively for the first 48 h to identify immediate compli- cations. <strong>Results:</strong> We found a predominance of male patients in our study population, with hypertension, dyslipidemia, and ischemic heart disease being the most common comorbidi- ties. After CEA, the observed complications included stroke, transient ischemic attack, cranial nerve palsy, neck hematoma, and severe hypotension. Statistical analyses were conducted to assess potential correlations between serum biomarker levels and these complications. Elevated preoperative levels of high-sensitivity C-reactive protein and matrix metalloproteinase-9 were associated with an increased risk of immediate postoperative complications during hospitalization. In contrast, high levels of monocyte chemoattractant protein-1 and oxidized low-density lipoprotein did not show a significant correlation with acute complications after CEA. <strong>Conclusions:</strong> This study highlights that CEA is a safe procedure with few acute postoperative complications. When such complications do occur, they are correlated with elevated preoperative levels of high-sensitivity C-reactive protein and matrix metal- loproteinase-9.</p>
</div>
</div>
</div>
</div>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Serum albumin concentration and the risk of cardiovascular disease and acute coronary syndrome — a narrative review</title>
		<link>https://www.jce.ro/article/serum-albumin-concentration-and-the-risk-of-cardiovascular-disease-and-acute-coronary-syndrome-a-narrative-review-2/</link>
		
		<dc:creator><![CDATA[Maria Czinege, Florina Ruța, Victoria Nyulas, Vasile-Bogdan Halațiu, Tiberiu Nyulas, Theodora Benedek]]></dc:creator>
		<pubDate>Mon, 03 Mar 2025 08:13:25 +0000</pubDate>
				<guid isPermaLink="false">https://www.jce.ro/?post_type=article&#038;p=2639</guid>

					<description><![CDATA[ABSTRACT Cardiovascular diseases are the primary cause of global health decline. Conditions <a class="more-link" href="https://www.jce.ro/article/serum-albumin-concentration-and-the-risk-of-cardiovascular-disease-and-acute-coronary-syndrome-a-narrative-review-2/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><strong>ABSTRACT</strong></p>
<p>Cardiovascular diseases are the primary cause of global health decline. Conditions that cause inflammation and excessive oxidation are present in the early development of the majority of cardiovascular diseases, including coronary artery disease and heart failure. Among the many physiological functions of albumin, its antioxidant, anti-inflammatory, anticoagulant, and antiaggregant properties are the most important. Low serum albumin levels are associated with the occurence of various cardiovascular diseases such as coronary artery disease, stroke, heart failure, and atrial fibrillation. Several recent meta-analyses support the idea that hypoalbu- minemia may act as a modifiable risk factor that increases oxidative stress and inflammation, contributing to the development and progression of cardiovascular diseases. However, it is un- clear whether correcting hypoalbuminemia can improve outcomes for patients with cardiovas- cular diseases and reduce mortality rates. In this regard, further research is crucial.</p>
</div>
</div>
</div>
</div>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Metoprolol Use in Hypertensive Pregnancy Disorder – a Single-center Study</title>
		<link>https://www.jce.ro/article/metoprolol-use-in-hypertensive-pregnancy-disorder-a-single-center-study/</link>
		
		<dc:creator><![CDATA[Corneliu-Florin Buicu, Melinda-Ildiko Mitranovici, Septimiu Voidazan, Marius Craina]]></dc:creator>
		<pubDate>Sun, 02 Mar 2025 08:16:04 +0000</pubDate>
				<guid isPermaLink="false">https://www.jce.ro/?post_type=article&#038;p=2632</guid>

					<description><![CDATA[ABSTRACT Hypertensive pregnancy disorder is among the leading causes of maternal and <a class="more-link" href="https://www.jce.ro/article/metoprolol-use-in-hypertensive-pregnancy-disorder-a-single-center-study/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p style="text-align: justify;"><strong>ABSTRACT</strong><br />
Hypertensive pregnancy disorder is among the leading causes of maternal and fetal mortality, affecting 5–7% of pregnant women. Beta-blockers are known to improve endothelial dysfunction and may be beneficial in the treatment of this condition. We carried out a retrospective observational study involving 80 pregnant women with hypertension, admitted to the Alexandru Simionescu County Hospital, Hunedoara, Romania, from May 1, 2021 to December 31, 2023. Systolic blood pressure, diastolic blood pressure, and hypertension treatment were compared between patients receiving metoprolol and patients receiving other antihypertensive medication. Preeclampsia and premature delivery occurred in a significantly higher proportion among those who received other antihypertensive medication (p = 0.006 and p = 0.021, respectively). Low Apgar score (Apgar 6) was encountered in 2.5% of cases. Intrauterine growth restriction did not occur in either study group, and the neonatal and maternal mortality rates were zero in both groups. Metoprolol had demonstrated its benefits in treating hypertensive pregnancy disorders. The final goal is improving maternal and fetal outcomes.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Arrhythmogenic Cardiomyopathy in Children. Case Series and Review of the Literature</title>
		<link>https://www.jce.ro/article/arrhythmogenic-cardiomyopathy-in-children-case-series-and-review-of-the-literature/</link>
		
		<dc:creator><![CDATA[Asmaa Carla Hagau, Diana-Ramona Iurian, Marian Pop, Ioana Șus, Carmen Corina Șuteu, Andrei-Samuel Dunareanu, Iolanda Muntean]]></dc:creator>
		<pubDate>Fri, 06 Sep 2024 06:29:43 +0000</pubDate>
				<guid isPermaLink="false">https://www.jce.ro/?post_type=article&#038;p=2570</guid>

					<description><![CDATA[ABSTRACT Arrhythmogenic cardiomyopathies (ACM) are rare inherited cardiac disorders, with an incidence <a class="more-link" href="https://www.jce.ro/article/arrhythmogenic-cardiomyopathy-in-children-case-series-and-review-of-the-literature/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p style="text-align: justify;"><strong>ABSTRACT</strong><br />
Arrhythmogenic cardiomyopathies (ACM) are rare inherited cardiac disorders, with an incidence below 1% in adults and an undetermined prevalence in pediatric populations. Formerly recognized primarily as arrhythmogenic right ventricular cardiomyopathy (ARVC), affecting exclusively the right ventricle (RV), recent diagnostic advancements have shed light on the involvement of the myocardium in ACM, revealing fibrous infiltration in both ventricles. In 2023, the European Society of Cardiology introduced updated phenotypic classifications of cardiomyopathy, highlighting the coexistence of multiple types within families and the potential transition from one cardiomyopathy to another. We present a case series comprising four pediatric cases of ARVC with diverse presentations and outcomes. Subsequent evaluations unveiled both left ventricle (LV) and RV dysfunction, culminating in a diagnosis of ARVC based on the 2020 diagnostic criteria. Additionally, genetic testing uncovered mutations in genes associated with cardiomyopathies. Cardiac magnetic resonance imaging (MRI) corroborated the biventricular involvement, aligning with a diagnosis of ACM per the 2020 Padua criteria. In conclusion, recent updates in diagnostic criteria have refined the classification of ACM, underscoring the importance of cardiac MRI and morphological features for precise diagnosis. Genetic testing has identified novel mutations linked to cardiomyopathy, emphasizing the significance of personalized treatment strategies and genetic counselling for affected individuals and their families.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
